Objectives To examine the problem of counterfeit drugs and its effects around the world, to
consider the likely directions the problem will take, and to propose options for controlling or …

Abstract Objectives: To describe (1) the international scope of counterfeit drugs,(2)
international and US anticounterfeiting initiatives, and (3) the enhanced roles and …

The problem of counterfeit drugs is increasingly becoming a top priority of drug regulatory
agencies, licit pharmaceutical manufacturers and healthcare professionals, and is of rising …

Background Counterfeit drugs comprise an increasing percentage of the US drug market
and even a larger percentage in less developed countries. Counterfeit drugs involve both …

“Counterfeit Drugs Kill” is the slogan the World Health Organization (WHO) uses in its anti‐
counterfeiting campaign. International organizations, governments of developed and …

Drugs that have been manufactured or packaged fraudulently are referred to as
counterfeit/fake/spurious/falsified drugs because they either lack active ingredients or have …

Counterfeit drugs have been defined as products deliberately and fraudulently produced
and/or mislabeled with respect to identity and/or source to make it appear to be a genuine …

Pharmaceutical products are not exempt from the practice of counterfeiting. In recent years,
many reports have become available demonstrating the presence of fake medicines on the …

This book overviews and integrates the business and technical issues that pharmaceutical
companies need to know in order to combat the major global problem of counterfeit …

Instruct clinicians on counterfeit drugs and their implications for patient health. Counterfeit
drugs imperil patients around the globe, and their penetration into the United States …